Texas

mRNA

Bayer and Amgen Join $120 Million Funding for Startup to Expand Genetic Drug Delivery

ReCode Therapeutics was founded around new science that may enable the delivery of genetic drugs to various organs in the body, and the startup has encouraging data for its therapeutic candidates targeting the lungs. Now the biotech startup $120 million to show that it can deliver on the technology’s promise in other organs and cell …

Bayer and Amgen Join $120 Million Funding for Startup to Expand Genetic Drug Delivery Read More »

Under new abortion laws, prenatal genetic test results may be late

Ann was 15 weeks pregnant with her fourth child when her prenatal genetic test results came back last August. The test suggested that her daughter, who she and her husband wanted to name Juliet, was missing one of her two X chromosomes — a condition called Turner syndrome, which can cause dwarfism, heart defects and …

Under new abortion laws, prenatal genetic test results may be late Read More »

Under new abortion laws, prenatal genetic test results may be late

Ann was 15 weeks pregnant with her fourth child when her prenatal genetic test results came back last August. The test suggested that her daughter, who she and her husband wanted to name Juliet, was missing one of her two X chromosomes — a condition called Turner syndrome, which can cause dwarfism, heart defects and …

Under new abortion laws, prenatal genetic test results may be late Read More »

Novartis Selects Precision Bio to Bring In Vivo Gene Editing Drugs for Blood Disorders

Genetic drugs in development for blood disorders include various therapies made by taking a patient’s cells and processing them outside the body. Novartis is one of the companies testing this approach, but also sees benefits in treating these diseases with therapies that work in the patient. The pharmaceutical giant is turning to Precision BioSciences’ technology …

Novartis Selects Precision Bio to Bring In Vivo Gene Editing Drugs for Blood Disorders Read More »